BackgroundThe first clinical study (NCT03671265) of first-line chemoradiotherapy combined with PD-1 blockade showed promising treatment outcomes in locally advanced esophageal squamous cell carcinoma (ESCC). However. partial patients did not respond to the combination treatment. The roles of dendritic cells (DCs) and macrophages in this combination treatment remain poorly understood. https://www.diegojavierfares.com/deal-alert-Has-the-Tribulation-Begun-Study-Guide-Avoiding-Confusion-and-Redeeming-the-Time-in-These-Last-Days-must-buy/